Annual General Meeting Presentation 2017

November 17, 2017 Kerry Rowe

AGM Presentation 2017

Post navigation

Alterity CEO David Stamler presents to US investors at the HC Wainwright Global Life Science Conference
Alterity to present at the 7th International Congress of Multiple System Atrophy
Alterity Half Year Results and Investor Webcast Notification
Alterity announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson’s disease clinical trials
Quarterly Cash Flow Report

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Annual General Meeting Presentation 2017

Related Posts

Dr David Stamler China Investor & Partnering Symposium Webcast

Dr David Stamler appointed CEO

European Commission Approves PBT2 Orphan Designation for Huntington’s Disease